Abstract
When prescribing intensive care to an unconscious patient, it is important to determine the etiological factor of the critical condition. The distribution of patients by neurotropic or vasotropic mechanism of disturbance of consciousness is extremely important for successful treatment and prevention of complications. Determination of autoantibodies to brain tissue is an important diagnostic criterion for the adequacy of intensive care. Administration of substances with succinic acid and D-fructose-1,6-diphosphate sodium salt hydrate is pathogenetically determined in this category of patients.
Reference12 articles.
1. Pharmacological interventions in traumatic brain injury: Can we rely on systematic reviews for evidence? / R. Gultekin, S. Huang, O. Clavisi [et al.] // Injury. 2016. Vol. 47(3). P. 516-524.
2. Popescu G.K. Allosteric Inhibitors of NMDA Receptor Functions / G.K. Popescu, S. Murthy, W.F. Borschel // Pharmaceuticals. – 2010. – Vol. 3. – P. 3240-3257.
3. Population pharmacodynamic modelling of lorazepam- and mid-azolam-induced sedation upon long-term continuous infusion in critically ill patients / E. Swart, K. Zuideveld, J. de Jongh [et al.] // Eur. J. Clin. Pharmacol. – 2006. – Vol. 62(3). P. – 185-194.
4. Prediction of outcome in traumatic brain injury patients using long-term qEEG features / A. Mikola, I. Ratsep, M. Sarkela, T. Lipping // Conf Proc IEEE Eng Med Biol Soc. – 2015. Vol. 10. P. 1532-1535.
5. Prediction of posttraumatic complaints after mild traumatic brain injury. Early symptoms and biochemical markers / J.R. de Kruijk, P. Leffers, P.P. Menheere [et al.] // J. Neural. Neurosurg. Psychiatry. – 2002. – Vol. 73 (6). – P. 727-732.